FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know

Published Jul 28, 2021

FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know

The Food and Drug Administration (FDA) has just approved a new treatment option for women with advanced uterine cancer. The combination of immunotherapy drugs Keytruda and Lenvima for the disease after initial treatment has failed. Here's what to know.

NOW
PLAYING
New Hope For Patients with Cervical Cancer
NOW
PLAYING
Sherry Pollex Promotes Ovarian Cancer Awareness at NASCAR Race
NOW
PLAYING
Ovarian Germ Cell Tumor Overview
NOW
PLAYING
Female Sexuality After Cancer - Connecting the Body and Mind & Finding the Right Products
NOW
PLAYING
COVID Vaccines Are Far Less Effective in Most Cancer Patients, Ineffective in Some, According to New Research
NOW
PLAYING
Colleen Donahue, Girlfriend of "Jon & Kate Plus 8" Star Jon Gosselin, Diagnosed With Triple-Negative Breast Cancer: What Are Treatment Options?

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.